Functional class of chronic heart failure and immunoinflammatory markers (IL-1β, IL-10) in patients with ischemic heart disease and type 2 diabetes

dc.contributor.authorНаріжна, Анна Василівна
dc.contributor.authorРиндіна, Наталія Геннадіївна
dc.contributor.authorNarizhna, Anna
dc.contributor.authorRyndina, Natalia
dc.date.accessioned2015-07-26T10:57:21Z
dc.date.available2015-07-26T10:57:21Z
dc.date.issued2015-05-14
dc.description.abstractThe presence of type 2 diabetes in patients with chronic heart failure on a background of ischemic heart disease is characterized by an imbalance of cytokine system working, which manifests by high concentrations of proinflammatory IL-1β and low anti-inflammatory cytokine - IL-10.The attempts of balance work of immunoinflammatory markers are characterized by both – pro- and anti-inflammatory link high activity in patients with chronic heart failure without type 2 diabetesuk_UA
dc.identifier.citationNarizhnaya A. Functional class of chronic heart failure and immunoinflammatory markers (IL-1β, IL-10) in patients with ischemic heart disease and type 2 diabetes / A. Narizhnaya, N. Ryndina // 8th International Scientific Interdisciplinary Conference for medical students and young scientists, May 14–15, 2015 : abstract book / Kharkiv National Medical University. – Kharkiv, 2015. – P. 87.uk_UA
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/9308
dc.language.isoenuk_UA
dc.publisherХНМУuk_UA
dc.subjectchronic heart failureuk_UA
dc.subjectischemic heart diseaseuk_UA
dc.subjecttype 2 diabetesuk_UA
dc.subjectinflammatoryuk_UA
dc.subjectinterleukinesuk_UA
dc.titleFunctional class of chronic heart failure and immunoinflammatory markers (IL-1β, IL-10) in patients with ischemic heart disease and type 2 diabetesuk_UA
dc.typeThesisuk_UA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
abstract Narizhna.doc
Size:
30.5 KB
Format:
Microsoft Word

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
6.52 KB
Format:
Item-specific license agreed upon to submission
Description: